Sinutab Sinus and Allergy

Quick links

Choose a section

Quick links to important sections

Advertisements

Sinutab Sinus and Allergy

Advertisements
Advertisements

Method of action: Analgesic, Antitussive Opioid

Treatment option:

Advertisements

Overview of Sinutab Sinus and Allergy

Quick Facts

Property Description
Active Ingredients Acetaminophen, Chlorpheniramine Maleate, Pseudoephedrine Hydrochloride
Form Tablet (Oral)
Pharmacological Class Upper Respiratory Combination Product
General Purpose Symptomatic relief of cold, allergy, and sinus discomforts
Origin Synthetic chemical compounds

What Type of Medicine is Sinutab Sinus and Allergy and Its Composition?

Sinutab Sinus and Allergy is an oral, fixed-dose combination product designed for the systemic relief of symptoms related to the common cold, allergies, and acute sinus distress. This medicine is typically supplied as a tablet or caplet, containing three distinct synthetic active ingredients to provide multiaction support.

The composition integrates an analgesic/antipyretic, an antihistamine, and a decongestant. The active ingredients are Acetaminophen (or Paracetamol, serving as an analgesic and antipyretic), Chlorpheniramine Maleate (a first-generation antihistamine), and Pseudoephedrine Hydrochloride (a sympathomimetic amine used for decongestion). The formulation is categorized as a combination product because it merges agents from multiple pharmacological classes into a single unit. This specific combination is recognized for its utility in addressing the simultaneous presentation of pain, congestion, and allergic symptoms.


Pharmacological Classification and General Purpose

Sinutab Sinus and Allergy is primarily classified as an upper respiratory combination product, strategically merging agents from different pharmacological classes to target the wide spectrum of cold and allergy symptoms. The general purpose of this formula is to offer symptomatic relief by concurrently addressing pain, congestion, and allergic responses.

The three components ensure its defined purpose: Acetaminophen reduces headache and fever; Pseudoephedrine provides relief from nasal congestion by causing vasoconstriction; and Chlorpheniramine mitigates allergy symptoms such as sneezing and a runny nose. The combination of Acetaminophen and Chlorpheniramine is used for relieving nasal discharge and sneezing associated with the common cold. The medicine is clinically recognized for its ability to reduce the discomfort from rhinorrhea and associated allergic symptoms, making it a choice for temporary relief during periods of seasonal allergy or cold.

Advertisements

What side effects are possible with Sinutab Sinus and Allergy?

Possible Side Effects and Safety Information

The safety profile for this medicine, which typically contains a combination of a pain reliever (Paracetamol), a decongestant (Pseudoephedrine), and an antihistamine (Chlorpheniramine), is structured around several regulatory domains.

Serious and Clinically Significant Adverse Reactions

Although rare, officially documented serious reactions include the potential for severe liver and kidney damage, especially with overdose of Paracetamol. The decongestant component carries a risk of hypertensive crisis and cardiovascular complications. Very rare, life-threatening skin reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have also been documented.

Common and Expected Adverse Reactions

Adverse effects are categorized by frequency and body system. Common side effects frequently reported and documented in official regulatory labels include drowsiness and sleepiness (due to the antihistamine), restlessness, insomnia, or anxiety (due to the decongestant), dry mouth, and headache.

System-Organ Class Examples of Documented Effects
Nervous System Drowsiness, Dizziness, Insomnia, Psychotic States
Cardiovascular Tachycardia, Palpitations, Hypertension
Gastrointestinal Nausea, Vomiting, Ischaemic Colitis

Safety-Related Restrictions and Limitations

Use of this medicine is contraindicated with or within 14 days of stopping Monoamine Oxidase Inhibitors (MAOIs). It is also restricted in patients with severe hypertension, severe coronary artery disease, or narrow-angle glaucoma. Due to the risk of drowsiness, patients must be warned against driving or operating machinery until they know how the medicine affects them. The duration of continuous use is officially limited, typically not exceeding 7 to 10 days.

Advertisements

Overdose and Emergency Response

The official regulatory profile for an overdose of this combination medicine is defined by the toxicities of its three active ingredients. Immediate medical attention must be sought for any suspected overdose, even if the individual feels well or shows no initial symptoms. This critical requirement is due to the risk of severe, delayed liver damage, which can be potentially fatal, primarily from the Acetaminophen component.

Documented presentations include serious Central Nervous System effects such as agitation, confusion, seizures, and hallucinations. Cardiovascular crisis, including severe hypertension and cardiac arrhythmias, is also an officially noted complication. Gastrointestinal signs such as nausea, vomiting, abdominal pain, and delayed jaundice may occur.

The severity classification includes life-threatening outcomes, such as fatal hepatic necrosis and organ failure. Specific populations, including children and individuals with non-cirrhotic alcoholic liver disease, are noted to have an increased risk of severe outcomes.

Management protocols emphasize symptomatic and supportive care. N-acetylcysteine is the documented antidote necessary to mitigate severe hepatic injury from Acetaminophen. Laboratory monitoring of liver function tests and drug plasma concentration is required in a clinical setting following exposure. This structure outlines the specific required emergency actions and the documented systemic and organ-specific risks.

Advertisements

Therapeutic Uses of Sinutab Sinus and Allergy

What Sinutab Sinus and Allergy Treats: Main Uses and Benefits

Sinutab Sinus and Allergy is commonly used across conditions presenting with acute episodes that require supportive symptom management. It is applied across domains where additional symptomatic support is needed, primarily addressing groups of symptoms that may appear suddenly and create temporary functional strain. This targeted approach helps ease the overall symptom burden.

The medicine is commonly used to help with conditions presenting with systemic or localized discomfort, such as allergic rhinitis (hay fever), the common cold, and acute sinus distress. It is relevant for easing symptoms related to physical discomfort, including fever, headaches, minor aches, and is applied in situations where symptoms create noticeable physiological strain like a stuffy or runny nose.

Quick Facts: Therapeutic Focus

Property Description
Symptom Domains Addressed Pain, fever, nasal congestion, and allergic discharge.
Context of Use Applied during phases when symptoms become more noticeable or disruptive during flare-ups.
Patient Benefit Provides support that helps ease the overall symptom burden and contributes to improved comfort.

Support for Allergic Discharge Symptoms

Sinutab is applicable within clinical settings that involve acute or disruptive symptom patterns like frequent sneezing and excessive runny nose (rhinorrhea) characteristic of allergic rhinitis. By addressing these symptoms that become more disruptive during flare-ups, the medication provides supportive relief when symptoms interfere with routine activities, particularly during seasonal periods.

Regulatory References

  1. NIH DailyMed resource on combination cold remedies
Advertisements

Eligibility and Restrictions for Use

The eligibility for using Sinutab Sinus and Allergy is strictly governed by official regulatory documents, which establish clear age, health, and concurrent medication restrictions.

Approved and Contraindicated Populations

Eligibility Group Status (Regulatory Wording)
Approved Age Adults and children aged 12 years and over
Contraindicated Age Children under the age of 12 years
Pregnancy/Lactation Not recommended (Conditional use)

Absolute Contraindications

Use of this medicine is prohibited for individuals with known hypersensitivity to any component (acetaminophen, chlorpheniramine, pseudoephedrine) or for patients who are taking, or have taken within the last 14 days, a Monoamine Oxidase Inhibitor (MAOI).

Official labeling also contraindicates use in patients with:

  • Severe or uncontrolled hypertension
  • Severe coronary artery disease
  • Severe renal or liver disease
  • Closed angle glaucoma
  • Diabetes mellitus or Hyperthyroidism

Conditional Use and Restrictions

Caution is required in older adults due to increased sensitivity, as well as in patients with moderate renal impairment or severe hepatic impairment. Individuals with difficulty in urination or an enlarged prostate should seek medical advice prior to use.

Advertisements

What should I know about interactions with other medicines?

This section outlines the officially documented interaction patterns for Sinutab Sinus and Allergy, based on regulatory labeling information.

Contraindicated Combinations

Co-administration with certain substances is formally prohibited by regulatory authorities:

  • Monoamine Oxidase Inhibitors (MAOIs): Use is contraindicated during or within 14 days following the discontinuation of MAOI treatment, due to the risk of a hypertensive crisis stemming from the Pseudoephedrine component.
  • Other Sympathomimetic Agents: This includes other decongestants, appetite suppressants, and amphetamine-like psychostimulants, due to the risk of potentiated cardiovascular effects.
  • Beta-blockers: Co-use is restricted due to the potential for significant hypertension.
  • Other Paracetamol/Acetaminophen-Containing Medicines: Use is prohibited to avoid exceeding maximum daily dosage and the associated risk of severe hepatic damage.

Other Documented Interaction Risks

Interacting Product Category Official Interaction Pattern Constraint/Outcome
Central Nervous System (CNS) Depressants (e.g., Hypnotics, Sedatives, Opioid Analgesics) Additive sedative effects with Chlorpheniramine. May prolong and intensify sedation; includes Alcohol (Ethanol).
Antihypertensive Drugs Pseudoephedrine may partially reverse the blood pressure-lowering effect. Requires caution; includes Methyldopa and Adrenergic neurone blockers.
Anticoagulants (e.g., Warfarin) Acetaminophen may enhance the anticoagulant effect with prolonged use. Requires monitoring.
Inhalation Anaesthetics (e.g., Halothane) Risk of cardiac dysrhythmias when Pseudoephedrine is used prior to anaesthesia. Requires precaution.
Aluminium-Hydroxide Preparations (Antacids) Officially documented to increase the absorption rate of Pseudoephedrine. Alters pharmacokinetic profile.

The interaction structure is defined by three primary components: the severe pressor risk of Pseudoephedrine, the CNS depression potential of Chlorpheniramine, and the metabolic and clearance effects of Acetaminophen on specific co-administered drugs like Zidovudine. This regulatory framework defines mandatory restrictions and required monitoring for identified substances.

Advertisements

Mechanism of Action

The action of Sinutab Sinus and Allergy involves two active ingredients that modulate the histamine signaling pathway and the autonomic nervous system.

Blocking Histamine Signaling at H1 Receptors

The antihistamine component, chlorpheniramine, acts as a competitive antagonist at Histamine H1 receptors. This molecular blockade suppresses the H1-mediated increases in capillary permeability and histamine-induced exocrine secretion from mucosal and lacrimal glands, thereby modulating fluid dynamics and nervous system stimulation.

Activating Adrenergic Receptors for Vasoconstriction

The decongestant component, pseudoephedrine, functions as a sympathomimetic agonist primarily on adrenergic alpha-receptors within the nasal and sinus lining. This activation triggers vasoconstriction (narrowing) of local arterioles, reducing blood flow and the volume of the mucosal tissue.

Modulating Central and Peripheral Pathways

Both ingredients can cross the blood-brain barrier, resulting in effects on the central nervous system (CNS), such as sedation from the antihistamine and mild stimulation from the decongestant. This combination operates by modulating distinct signaling pathways: histamine antagonism and adrenergic agonism.

Advertisements

Dosage and Administration Information

How to Use Sinutab Sinus and Allergy

The usage of Sinutab Sinus and Allergy, a fixed-dose combination product, is governed by instructions that define the precise administration method and dosing limits. The medicine is approved for oral administration as a solid form, such as a tablet or caplet. Solid oral forms must be swallowed whole with fluid, typically water, and should not be crushed or chewed.


Official Dosing and Frequency Principles

The standard regimen for adults and adolescents 12 years of age and older is typically two tablets or caplets taken every four to six hours. This establishes an intermittent, as-needed frequency pattern for use during acute episodes. The total number of tablets taken must not exceed eight tablets within a 24-hour period for the standard formulation.

A critical instruction is the daily maximum constraint for the analgesic component: the total intake of Acetaminophen (Paracetamol) from all sources, including this product, must not exceed 4,000 milligrams (4 grams) per day. The product may be administered with or without food.


Duration and Special Conditions

Use of this product is restricted to short-term use only for temporary symptom relief. Standard limits for use for pain are no more than five days and use for fever no more than three days without consulting a healthcare professional. The adult-strength formulation is not recommended for children under 12 years of age. Administration is restricted in conjunction with any other medication containing Acetaminophen or similar active ingredients to prevent exceeding established daily limits.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sinutab Sinus and Allergy

Evidence for Use in Common Cold Symptom Management

The research base for this combination product has primarily involved studies of symptoms associated with the common cold. These trials utilized short-term Randomized Controlled Trials (RCTs) used in research exploring how symptoms change over time. These studies typically involved otherwise healthy adults who were experiencing conditions associated with acute or disruptive episodes of the common cold.

Studies monitored patient-reported outcomes describing perceived discomfort, including scores for individual symptoms such as headache, fever, and congestion. The trials reported how symptoms evolved in the observed populations over the defined time intervals. However, the follow-up durations were limited, meaning there is limited information for long-term outcomes or sustained effects, and the results apply only to the populations studied.


Evidence for Acute Sinus Distress and Associated Pain

Research has also examined the product's components in managing acute outcomes related to systemic or functional imbalance, specifically those related to sinus distress. The evidence for this area includes studies that examined the decongestant (Pseudoephedrine) and analgesic (Acetaminophen) components. These studies were applied in research contexts involving fluctuating or unstable symptoms such as sinus pressure, congestion, and associated pain.

Researchers explored measured outcomes, including scores for localized pain and the degree of nasal congestion. The findings describe group patterns for how patients reported their experience of discomfort after short-term use. A key research limitation is that comparative evidence is lacking for the specific three-part combination product when tested solely for acute sinus distress, separate from general cold symptoms.


What Is Still Uncertain About the Evidence Base

Key uncertainties remain in several areas. For allergic rhinitis symptoms, research examined the antihistamine component (Chlorpheniramine Maleate) in trials relevant in assessing short-term or episodic symptom patterns. The long-term effects are not well characterized in the context of chronic or seasonal allergy management. Furthermore, comparative evidence is limited between this specific combination and other available upper respiratory formulas, and the evidence quality varies across studies due to heterogeneity in dosages.

Key Studies & References

  1. First generation antihistamines for allergic rhinitis: a systematic review of the evidence and expert opinion
  2. Acetaminophen, Chlorpheniramine Maleate, and Pseudoephedrine Hydrochloride Tablets Official Labeling (DailyMed)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sinutab Sinus and Allergy (FAQ)

Q: What should I do if I miss a dose of Sinutab?

If a dose is missed, official product information indicates it can be taken when remembered, provided that the required interval of at least four to six hours from the last dose is maintained. Regulatory documents caution that if it is almost time for the next dose, the missed one should generally be skipped, as doubling a dose is not recommended.

Q: Is it safe to take Sinutab while I'm pregnant or breastfeeding?

According to official product information, use of this medicine is generally not recommended during pregnancy or while breastfeeding. The product contains pseudoephedrine, which is sometimes avoided during the first trimester of pregnancy and may reduce milk supply. Components of the medicine can also pass into breast milk. Use in these populations should be discussed with a healthcare professional.

Q: How long until I feel the effects of the medicine?

Studies and official information indicate that the decongestant component, pseudoephedrine, is generally associated with symptom relief beginning within 30 minutes of administration. The overall symptom relief from the combination product is related to its four-to-six-hour recommended dosing interval.

Q: What are the signs of an overdose and what should I do?

Overdose is a medical emergency according to regulatory warnings. Signs of an overdose from the acetaminophen component may include nausea, vomiting, or abdominal pain, which can be followed by serious liver damage. Regulatory warnings state that if an overdose is suspected, the use of the product should be stopped immediately. Emergency medical attention or contact with a poison control center is advised, even if symptoms have not yet appeared.

Q: How do I read the expiration date on the packaging?

The expiration date (often labeled EXP) on the packaging indicates the final date the medicine is guaranteed to retain its full strength, quality, and purity when stored correctly. It is officially required that this date be followed. If the date lists a month and year, the product is considered expired after the very last day of that stated month.

Advertisements

How should Sinutab Sinus and Allergy be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Sinutab Sinus and Allergy must strictly follow regulatory guidance to ensure product stability and safety. The medicine must be stored at room temperature, typically between 20 C and 25 C. Storage environments must protect the product from moisture and light; therefore, storing it in high-humidity areas, such as a bathroom, is prohibited. The container must be kept tightly closed and in its original packaging until the expiration date. A mandatory safety instruction requires the product to be kept out of sight and reach of children and pets at all times.

For disposal, unused or expired Sinutab should ideally be returned to a drug take-back program. If this is unavailable, the product must be mixed with an undesirable substance (e.g., dirt or coffee grounds), sealed in a bag, and disposed of in household trash. It is explicitly stated that the medicine must not be flushed down the toilet or poured into a drain unless specific label instructions exist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sinutab Sinus and Allergy found in:

A-Z Index: